Form D — Hexamer Therapeutics, Inc
0001797915-26-000002 · filed Sep 15, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $2,500,000
- Total sold
- $500,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Hexamer Therapeutics, Inc
- CIK
- 1797915
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2345 NE HOPKINS CT
PULLMAN, WA 99163 - Phone
- 509-715-9251
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Robert H Bogden · Executive OfficerPullman, WA Find on LinkedIn ↗
-
Colin Collins · DirectorVancouver, A1 Find on LinkedIn ↗
-
Keith Miller · DirectorMoscow, ID Find on LinkedIn ↗
-
R. Scott Blackley · DirectorLeesburg, VT Find on LinkedIn ↗
-
Stephen Crawford · DirectorBronxville, NY Find on LinkedIn ↗
-
Brad Call · DirectorPullman, WA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗